Skip to main content

Utah Medical Products Inc

UTMD
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000706698

In the last 90 days, Utah Medical Products Inc insiders filed 1 open-market purchase and 0 sales; 116 institutions reported holding it in 13F filings for Q2 2026, worth $159.9M in total; no superinvestor holds it.

Holders of 5% or more of UTMD

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Utah Medical Products Inc, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of UTMD
HolderLatest formStakeChangeFirst filedLatest filingFiling
Brandes Investment Partners, LP13G/A14.90%475.2K shares+0.80 ppfrom 14.10%May 14, 20255 filingsAug 14, 2026SEC
Dimensional Fund Advisors LP13G/A6.10%197.5K shares–Oct 31, 20242 filingsJul 15, 2025SEC
Renaissance Technologies LLC13G/A5.52%175.8K shares−1.18 ppfrom 6.70%Feb 11, 20216 filingsAug 13, 2026SEC
BlackRock, Inc.13G5.30%172.7K shares+0.33 ppfrom 4.97%Feb 5, 20252 filingsJul 17, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

37 Schedule 13D and 13G filings on Utah Medical Products Inc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on UTMD
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 14, 20261:34 PM ETBrandes Investment Partners, LPand 1 other13G/A14.90%475.2K shares+0.80 ppfrom 14.10%Jun 30, 2026SEC
Aug 13, 20264:25 PM ETRenaissance Technologies LLCand 1 other13G/A5.52%175.8K shares−1.18 ppfrom 6.70%Jun 30, 2026SEC
May 14, 20265:44 PM ETBrandes Investment Partners, LP13G/A14.10%449.7K shares+3.70 ppfrom 10.40%Mar 31, 2026SEC
Mar 27, 20261:53 PM ETVanguard Group Inc13G/A0.00%0 shares–Below 5%Mar 13, 2026SEC
Sep 5, 20254:59 PM ETBrandes Investment Partners, LP13G/A10.40%333.2K shares+2.00 ppfrom 8.40%Aug 31, 2025SEC
Aug 12, 20254:29 PM ETBrandes Investment Partners, LP13G/A8.40%271.5K shares+1.00 ppfrom 7.40%Jun 30, 2025SEC
Jul 17, 20258:12 PM ETBlackRock, Inc.13G5.30%172.7K shares+0.33 ppfrom 4.97%Jun 30, 2025SEC
Jul 15, 20254:03 PM ETDimensional Fund Advisors LP13G/A6.10%197.5K shares–Jun 30, 2025SEC
May 14, 20255:09 PM ETBrandes Investment Partners, LP13G7.40%242.4K sharesNewMar 31, 2025SEC
Feb 5, 20251:23 PM ETBlackRock, Inc.13G/A4.97%168.6K shares–Below 5%Dec 31, 2024SEC
Jan 8, 20259:54 AM ETFMR LLCand 1 other13G/A2.70%92.4K shares–Below 5%Dec 31, 2024SEC
Nov 13, 20243:57 PM ETRenaissance Technologies LLCand 1 other13G/A6.70%230.6K shares–Sep 30, 2024SEC
Nov 12, 2024Vanguard Group Inc13G/AOld format–––SEC
Nov 12, 2024FMR LLC13G/AOld format–––SEC
Nov 4, 2024Vanguard Group Inc13G/AOld format–––SEC
Oct 31, 2024Dimensional Fund Advisors LP13GOld format–New–SEC
Feb 14, 2024T. Rowe Price Investment Management, Inc.13G/AOld format–––SEC
Feb 13, 2024Renaissance Technologies LLC13G/AOld format–––SEC
Feb 9, 2024FMR LLC13G/AOld format–––SEC
Jan 29, 20245:25 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 14, 2023T. Rowe Price Investment Management, Inc.13GOld format–New–SEC
Feb 13, 2023Renaissance Technologies LLC13G/AOld format–––SEC
Feb 9, 2023Vanguard Group Inc13G/AOld format–––SEC
Feb 9, 2023FMR LLC13G/AOld format–––SEC
Feb 1, 20234:54 PM ETBlackRock Inc.13G/AOld format–––SEC
Aug 10, 2022Price T Rowe Associates Inc13G/AOld format–––SEC
Jun 10, 2022Price T Rowe Associates Inc13G/AOld format–––SEC
Feb 14, 2022Price T Rowe Associates Inc13G/AOld format–––SEC
Feb 11, 2022Renaissance Technologies LLC13G/AOld format–––SEC
Feb 10, 2022Vanguard Group Inc13G/AOld format–––SEC
Feb 9, 2022FMR LLC13G/AOld format–––SEC
Jan 31, 20225:49 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 16, 2021Price T Rowe Associates Inc13G/AOld format–––SEC
Feb 11, 2021Renaissance Technologies LLC13G/AOld format–––SEC
Feb 10, 2021Vanguard Group Inc13GOld format–New–SEC
Feb 8, 2021FMR LLC13G/AOld format–––SEC
Feb 1, 20218:23 AM ETBlackRock Inc.13G/AOld format–––SEC

Form 144: proposed insider sales

2 notices from officers, directors and other affiliates planning to sell Utah Medical Products Inc shares, newest first.

Form 144 notices for UTMD
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Jun 14, 20238:50 AM ETCornwell Kevin LOfficer10.0K$997.6KJun 14, 2023FIDELITY BROKERAGE SERVICES LLCSEC
May 18, 20234:36 PM ETRichins Paul ODirector700$64.4KMay 18, 2023SCHWAB CHARLES CORPSEC